These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

296 related items for PubMed ID: 17156345

  • 1. Combined mediator blockade or topical steroid for treating the unified allergic airway.
    Barnes ML, Menzies D, Fardon TC, Burns P, Wilson AM, Lipworth BJ.
    Allergy; 2007 Jan; 62(1):73-80. PubMed ID: 17156345
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effect of nasal steroid treatment on airway inflammation determined by exhaled nitric oxide in allergic schoolchildren with perennial rhinitis and asthma.
    Pedroletti C, Lundahl J, Alving K, Hedlin G.
    Pediatr Allergy Immunol; 2008 May; 19(3):219-26. PubMed ID: 18399898
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Clinical studies of the DP1 antagonist laropiprant in asthma and allergic rhinitis.
    Philip G, van Adelsberg J, Loeys T, Liu N, Wong P, Lai E, Dass SB, Reiss TF.
    J Allergy Clin Immunol; 2009 Nov; 124(5):942-8.e1-9. PubMed ID: 19748656
    [Abstract] [Full Text] [Related]

  • 6. Antiasthmatic effects of mediator blockade versus topical corticosteroids in allergic rhinitis and asthma.
    Wilson AM, Orr LC, Sims EJ, Dempsey OJ, Lipworth BJ.
    Am J Respir Crit Care Med; 2000 Oct; 162(4 Pt 1):1297-301. PubMed ID: 11029334
    [Abstract] [Full Text] [Related]

  • 7. A randomized study comparing the effect of loratadine added to montelukast with montelukast, loratadine, and beclomethasone monotherapies in patients with chronic asthma.
    Lu S, Liu N, Dass SB, Reiss TF.
    J Asthma; 2009 Jun; 46(5):465-9. PubMed ID: 19544166
    [Abstract] [Full Text] [Related]

  • 8. The effect of montelukast on bronchial provocation tests and exhaled nitric oxide levels in asthmatic patients.
    Berkman N, Avital A, Bardach E, Springer C, Breuer R, Godfrey S.
    Isr Med Assoc J; 2003 Nov; 5(11):778-81. PubMed ID: 14650101
    [Abstract] [Full Text] [Related]

  • 9. Effect of montelukast on lung function in asthma patients with allergic rhinitis: analysis from the COMPACT trial.
    Price DB, Swern A, Tozzi CA, Philip G, Polos P.
    Allergy; 2006 Jun; 61(6):737-42. PubMed ID: 16677244
    [Abstract] [Full Text] [Related]

  • 10. Effect of nebulized beclomethasone on airway inflammation and clinical status of children with allergic asthma and rhinitis: a randomized, double-blind, placebo-controlled study.
    Profita M, Riccobono L, Bonanno A, Chanez P, Gagliardo R, Montalbano AM, Albano GD, Liotta G, Gjomarkaj M, La Grutta S.
    Int Arch Allergy Immunol; 2013 Jun; 161(1):53-64. PubMed ID: 23257680
    [Abstract] [Full Text] [Related]

  • 11. Adherence with montelukast or fluticasone in a long-term clinical trial: results from the mild asthma montelukast versus inhaled corticosteroid trial.
    Rand C, Bilderback A, Schiller K, Edelman JM, Hustad CM, Zeiger RS, MIAMI Study Research Group.
    J Allergy Clin Immunol; 2007 Apr; 119(4):916-23. PubMed ID: 17349681
    [Abstract] [Full Text] [Related]

  • 12. Effects of monotherapy with intra-nasal corticosteroid or combined oral histamine and leukotriene receptor antagonists in seasonal allergic rhinitis.
    Wilson AM, Orr LC, Sims EJ, Lipworth BJ.
    Clin Exp Allergy; 2001 Jan; 31(1):61-8. PubMed ID: 11167952
    [Abstract] [Full Text] [Related]

  • 13. Clinical efficacy and pharmacokinetic profiles of intranasal and oral cetirizine in a repeated allergen challenge model of allergic rhinitis.
    Korsgren M, Andersson M, Borgå O, Larsson L, Aldén-Raboisson M, Malmqvist U, Greiff L.
    Ann Allergy Asthma Immunol; 2007 Apr; 98(4):316-21. PubMed ID: 17458426
    [Abstract] [Full Text] [Related]

  • 14. Targeting adenosine receptors in the treatment of allergic rhinitis: a randomized, double-blind, placebo-controlled study.
    Rimmer J, Peake HL, Santos CM, Lean M, Bardin P, Robson R, Haumann B, Loehrer F, Handel ML.
    Clin Exp Allergy; 2007 Jan; 37(1):8-14. PubMed ID: 17210036
    [Abstract] [Full Text] [Related]

  • 15. A comparison of topical budesonide and oral montelukast in seasonal allergic rhinitis and asthma.
    Wilson AM, Dempsey OJ, Sims EJ, Lipworth BJ.
    Clin Exp Allergy; 2001 Apr; 31(4):616-24. PubMed ID: 11359431
    [Abstract] [Full Text] [Related]

  • 16. Antihistamines added to an antileukotriene in treating seasonal allergic rhinitis: histamine and leukotriene antagonism.
    Ciprandi G, Tosca MA, Milanese M, Schenone G, Ricca V.
    Eur Ann Allergy Clin Immunol; 2004 Feb; 36(2):67-70, 72. PubMed ID: 15061398
    [Abstract] [Full Text] [Related]

  • 17. Montelukast decreased exhaled nitric oxide in children with perennial allergic rhinitis.
    Hung CH, Hua YM, Hsu WT, Lai YS, Yang KD, Jong YJ, Chu YT.
    Pediatr Int; 2007 Jun; 49(3):322-7. PubMed ID: 17532829
    [Abstract] [Full Text] [Related]

  • 18. Nasal nitric oxide and nasal eosinophils decrease with levocetirizine in subjects with perennial allergic rhinitis.
    Bautista AP, Eisenlohr CP, Lanz MJ.
    Am J Rhinol Allergy; 2011 Jun; 25(6):383-7. PubMed ID: 22185740
    [Abstract] [Full Text] [Related]

  • 19. [Effects of H1 blocker and inhaled corticosteroids on asthmatic patients with allergic rhinitis].
    He WQ, Zheng JP, Ran PX, Liu HZ, Lin H, Cai DM, Xu JM, Zhong NS.
    Zhonghua Jie He He Hu Xi Za Zhi; 2003 Mar; 26(3):157-60. PubMed ID: 12816681
    [Abstract] [Full Text] [Related]

  • 20. Randomized placebo-controlled trial comparing montelukast and cetirizine for treating perennial allergic rhinitis in children aged 2-6 yr.
    Chen ST, Lu KH, Sun HL, Chang WT, Lue KH, Chou MC.
    Pediatr Allergy Immunol; 2006 Feb; 17(1):49-54. PubMed ID: 16426255
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.